Skip to content
Events

Details

The 46th Lorne Genome conference will be held at Mantra Lorne from 16th-19th February 2025.   

The conference is a chance for the international gene regulation community to come together in person and discuss the latest science. There will be lots of time to meet during the social events, have a swim at the beach and see the beautiful local marsupials and birdlife!

Lorne Genome 2025 will feature chromatin structure, architecture and nuclear organisation, gene expression, histone modifications and variants, RNA functions in the genome, the genome in disease, the genome in development, epigenetics and genome stability, genome studies in model organisms, population and evolutionary genomics, computational biology and bioinformatics and novel approaches to study the genome.

The program will start around lunchtime on Sunday 16th February and finish around lunchtime on Wednesday 19 February 2025. 

Date & Time
16 Feb. 2025 – 19 Feb. 2025
Location
Lorne, Victoria (Australia)
Topic
Cancer research, Cellular & molecular biology, Genetic & rare diseases, Agrigenomics, Oncology, Neuroscience, Pharmacogenomics
Visit Website

Related Events

Feb 26
Illumina’s Integrated Workflow for Rare and Undiagnosed Genetic Disease Research
Feb 26, 2025
Individuals suspected of having a rare disease often face a long search for an answer. With up to 80% of rare diseases being genetic or having a genetic subtype, it is imperative to interrogate the genome to find answers and shorten the diagnostic odyssey. This webinar provides an overview of the integrated workflow provided by Illumina for rare and undiagnosed diseases research. Starting from library prep to sequencing and informatics, Illumina empowers researchers to find the answers they seek in rare and undiagnosed disease research.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.